Log in to search using one of your social media accounts:

 

Predicting Risk for Opioid Misuse in Chronic Pain Predicting Risk for Opioid Misuse in Chronic Pain
Might something as simple as a single question assessing pain catastrophizing be useful for predicting risk of opioid misuse in chronic pain sufferers?Journal of the American Board of Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Abbott, Nevro tout spinal cord stimulation tech
Abbott (NYSE:ABT) and Nevro (NYSE:NVRO) touted their spinal cord stimulation technologies at the annual North American Neurological Society meeting in Las Vegas. Two-year data from Abbott’s 42-patient Sunburst study revealed that a majority of patients chose its BurstDR therapy when given the choice during the long-term follow-up period and that stimulation from BurstDR provided pain relief through 24 months. Patient preference for Abbott’s BurstDR system grew over time, the company pointed out – 68% of patients chose BurstDR at 12 months compared to 81% at two years. “The BurstDR waveform is b...
Source: Mass Device - January 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation Pain Management Wall Street Beat Abbott nevro Source Type: news

What Treatment is Recommended for Common Headaches?
Discussion Headache is pain in the scalp, forehead, orbits and temple. Facial and neck pain are usually excluded from this definition. It is a common problem with more than 6 million pediatric patients having migraine. Headaches can also have co-morbidities and more than 1 primary headache type can co-exist. The costs are high both economically and in the quality of life for the patients and families. A review of common headache types and indications for neuroimaging can be found here. Treatment is necessarily multi-pronged. Patients should understand their diagnosis so they can understand what reasonably can be expected...
Source: PediatricEducation.org - January 15, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Boston Scientific touts spinal cord stim pain-relief trial
This study provides data on people who have suffered with chronic pain for years and who pose some of the biggest challenges in the long-term use of SCS. The results demonstrated that giving patients the choice to use sub-perception or paresthesia-based therapy provides superior patient outcomes and affirms that SCS is a clinically valuable treatment option.” The trial showed that if patients are able to choose the type of therapy that brings them the most effective pain relief, the number of people whose pain was effectively controlled by SCS jumped by 62%. More than half of the patients in one of the study’s ...
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Neuromodulation/Neurostimulation Pain Management Spinal Wall Street Beat Boston Scientific Source Type: news

Stimwave raises $50m for consumer launch of chronic pain neuromod device
Stimwave said this week that it raised more than $50 million from a consortium of unnamed investors for the consumer launch of its Freedom neuromodulation device for treating chronic pain. Pompano Beach, Fla.-based Stimwave said the Freedom stimulator is the sole FDA-approved wireless, micro-sized device cleared for treating neuropathic pain. The device uses a tiny injectable microchip to deliver small pulses of energy to nearby nerves to relieve pain. “The key to Stimwave pain management is the ability to allow the pain sufferer to control their pain wherever and whenever they want,” chairwoman and c...
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Neuromodulation/Neurostimulation Pain Management Stimwave Source Type: news

Does an exploding brain network cause chronic pain?
(Michigan Medicine - University of Michigan) New research reports that hyperreactive brain networks could play a part in the hypersensitivity of fibromyalgia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 12, 2018 Category: International Medicine & Public Health Source Type: news

Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review - Witkiewitz K, Vowles KE.
The dramatic increase in opioid misuse, opioid use disorder (OUD), and opioid-related overdose deaths in the United States has led to public outcry, policy statements, and funding initiatives. Meanwhile, alcohol misuse and alcohol use disorder is a highly ... (Source: SafetyLit)
Source: SafetyLit - January 12, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Medtronic Tweaks its New Pain Pump System
FDA approved a new clinician programmer for use with Medtronic's SynchroMed II intrathecal drug delivery system, an implantable pump that provides targeted drug delivery for patients suffering from chronic pain and severe spasticity. The new technology was designed to simplify therapy management for clinicians by providing them with visual tools and intuitive workflows. The SynchroMed II clinician programmer is a new application that can be used on a tablet and features visual enhancements for a side-by-side comparison of therapy changes. The new app also communicates wirelessly to the SynchroMed II pump with automate...
Source: MDDI - January 12, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: Implants Source Type: news

Boston Scientific scores FDA nod for personalized pain device
Marlborough-based Boston Scientific said Thursday that the FDA approved a first-of-its-kind device that uses electrical pulses to treat chronic pain. Boston Scientific (NYSE: BSX) said that the device, called the Spectra WaveWriter, was the first product approved by the FDA that can simultaneously provide two types of pain relief: paresthesia-based therapy, in which patients feel a slight tingling sensation, and sub-perception therapy, in which there is no such sensation. The device is designed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 11, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System
System offers non-opioid treatment option with multiple therapies for people with chronic pain MARLBOROUGH, Mass., Jan. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food a... Devices, FDA Boston Scientific, Spectra WaveWriter, Spinal Cord Stimulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2018 Category: Pharmaceuticals Source Type: news

FDA approves Boston Scientific ’ s Spectra WaveWriter chronic pain device
Boston Scientific (NYSE:BSX) said today that it won pre-market approval from the FDA for its Spectra WaveWriter spinal cord stimulator for treating chronic pain. Spectra WaveWriter is designed to deliver electrical pulses of varying frequency, pulse width and amplitude to the spinal cord. Marlborough, Mass.-based Boston Scientific touted the device as the U.S. market’s first and only such system designed to provide both paresthesia-based and sub-perception therapy. Paresthesia is a low-level tingling sensation that accompanies SCS treatment for some patients; sub-perception therapy does not create pare...
Source: Mass Device - January 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Boston Scientific Source Type: news

Study Gets to the Core of Back Pain in Runners
Title: Study Gets to the Core of Back Pain in RunnersCategory: Health NewsCreated: 1/10/2018 12:00:00 AMLast Editorial Review: 1/11/2018 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - January 11, 2018 Category: Anesthesiology Source Type: news

How Medtronic Wants to & #039;Evolve & #039; Spinal Stimulation
Medtronic seeks to prove high-dose spinal stimulation just as good as low-dose About 9,000 patients with chronic lower back and leg pain have had a personal trial of Medtronic’s Evolve workflow to help their physicians decide how much high- and/or low-spinal cord stimulation they need to manage pain. Now the company has launched an official postmarket trial of Evolve, which it recommends for use with its Intellis implantable neurostimulator. Evolve received FDA approval and the CE Mark last year. Medtronic hopes that the Vectors study will produce step-by-step instructions for physicians on how to best use Intellis&r...
Source: MDDI - January 10, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Implants Source Type: news

Patients' concerns over chronic pain treatment removal
More than 80 people in Hull and East Yorkshire face losing their NHS treatment for chronic pain. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 10, 2018 Category: Consumer Health News Source Type: news

Stigma continues to hamper response to opioid epidemic
(Oregon Health& Science University) Efforts to reverse the nation's opioid epidemic remain beset by the stigma associated with drug use, a group of OHSU researchers write in a year-end review. The researchers emphasize the need for the American health care system to embrace medications such as methadone to treat opioid use disorder, provide addiction treatment in primary care clinics and develop non-addictive alternatives for chronic pain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic launches post-market SCS programming study
Medtronic (NYSE:MDT) said today it launched a post-market clinical study of its Evolve SM workflow spinal cord stimulation optimization program, having enrolled the first patient in the study. The first patient in the trial was enrolled at Wilmington, Del.’s Center for Interventional Pain & Spine, the company said. “Our goal is to improve or restore function. Even with all of today’s technological advances, chronic pain can be challenging to manage; this is further complicated by the opioid crisis. Standard treatment guidance has the potential to help optimize pain relief, and the Vectors Post Ma...
Source: Mass Device - January 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation Pain Management Medtronic Source Type: news

Venture capital-backed Zyga Technology sold to Florida firm
Venture capital-backed med-tech company Zyga Technology Inc. has reached a deal to be sold to RTI Surgical Inc. for an undisclosed amount. Zyga sells tools physicians use to treat sacroiliac joint dysfunction, a condition that can cause chronic pain, especially in the lower back. The company’s products help stabilize joints that connect the hip and spine, preventing them from rubbing together and causing pain. Bob Assell, a former executive at medical-device maker TranS1 Inc., launched Zyga in… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 8, 2018 Category: Health Management Authors: Katharine Grayson Source Type: news

Doctors call for painkiller crackdown over addiction fears
More than a million Britons have been prescribed pregabalin and gabapentin to treat chronic pain and anxiety. (Source: the Mail online | Health)
Source: the Mail online | Health - January 7, 2018 Category: Consumer Health News Source Type: news

Tips For Managing Chronic Pain For A Better Life
Being diagnosed with a chronic pain condition can change a person’s life. This type of pain--defined as lasting longer than 3-6 months--can be the result of many different factors, such as injury, arthritis, or a condition like fibromyalgia, but the effects are similar in many cases: they make life harder. You may find it more difficult to do basic household chores or to find the energy to exercise; it may be harder to concentrate at work or school, and you may be more at risk for depression and anxiety. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - January 6, 2018 Category: Orthopaedics Tags: Featured Viewpoints News Source Type: news

Skelaxin vs. Baclofen
Title: Skelaxin vs. BaclofenCategory: MedicationsCreated: 1/5/2018 12:00:00 AMLast Editorial Review: 1/5/2018 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - January 5, 2018 Category: Anesthesiology Source Type: news

Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents
No studies met the criteria for this review and therefore the authors were unable to draw any conclusions regarding the benefits and harms of using NSAIDs to treat chronic cancer-related pain in children and adolescents. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2018 Category: Consumer Health News Source Type: news

'I am free in my wheelchair but pain does have a say in it though': the meaning and experience of quality of life when living with paraplegia and chronic pain - Hughes M, Burton AE, Dempsey RC.
This study investigated how wheelchair-using individuals with paraplegia and chronic pain make sense of the factors associated with quality of life based on interviews using photo-elicitation and interpretative phenomenological analysis. Three superordinat... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Trauma and pain in family-orientated societies - Kizilhan JI.
People from family-oriented societies in particular, in addition to having a post-traumatic stress disorder (PTSD) suffer from chronic pain and physical complaints. Such people have a different understanding of physical illness and pain and, compared to pa... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

5 medtech stories we missed this week: Dec. 29, 2017
[Image from unsplash.com]From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory and marketing partner in India. Morulaa HealthTech will help bring NanoVibronix’s products to India, including its UroShield, WoundShield and PainShield. Morulaa HealthTech also has an in...
Source: Mass Device - December 29, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News Cardiovascular Catheters Regulatory/Compliance Guided Therapeutics Inc. Impulse Dynamics K2M MedTech Muscle Activation Technique nanovibronix neuxtechnologies Source Type: news

Assessing Risk of Problematic Analgesic Use for Chronic Pain Assessing Risk of Problematic Analgesic Use for Chronic Pain
Which validated tool is best for risk assessment and monitoring of chronic non-cancer pain patients being considered for analgesic drugs with abuse potential?British Journal of Anaesthesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Alternatives to Opioids in the Management of Chronic Pain Alternatives to Opioids in the Management of Chronic Pain
This study examines the current evidence on the use of nonopioid analgesics for the most common noncancer chronic pain conditions, including back pain, fibromyalgia, diabetic neuropathy, and more.Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Health Tip: Sit and Stand Up Straight
Title: Health Tip: Sit and Stand Up StraightCategory: Health NewsCreated: 12/26/2017 12:00:00 AMLast Editorial Review: 12/26/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - December 26, 2017 Category: Anesthesiology Source Type: news

Suicidal behaviors in patients with rheumatic diseases: a narrative review - Calandre EP, Rico-Villademoros F, Slim M.
Chronic rheumatic disorders are characterized by inflammation and chronic pain, and both anxiety and depression have been frequently observed in these patients. Depression and chronic pain are recognized as risk factors for the development of suicidal beha... (Source: SafetyLit)
Source: SafetyLit - December 25, 2017 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Genetic Variation of Brain-Derived Neurotrophic Factor (BDNF) May Play Role in Chronic Pain After Surgery
A study conducted in China and published online in the journal Anesthesiology suggests that genetic variation of brain-derived neurotrophic factor (BDNF) may be linked with an increased risk of chronic postsurgical pain.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - December 24, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

5 medtech stories we missed this week: Dec. 22, 2017
[Image from unsplash.com]From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its company into the U.S. Hepa Wash recently introduced an Advanced Organ Support (ADVOS) procedure that offers multi-organ support for liver, lungs and kidneys while correcting acid-base balance disorders. 2. FDA clears Camber Spine interbody device ...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Implants Pain Management Regulatory/Compliance camberspine Hepa Wash In2Bones MedTech nanovibronix Stimwave Source Type: news

Most people with blood clots should not take clot-busting drugs : New research finds they cripple patients' mobility
(Natural News) A study published in The New England Journal of Medicine revealed that not all patients with deep vein thrombosis (DVT) require clot-clearing drugs and devices as the treatments did not reduce the risk of developing post-thrombotic syndrome, a condition characterized by chronic limb pain and swelling. According to the experts, this complication leads to... (Source: NaturalNews.com)
Source: NaturalNews.com - December 21, 2017 Category: Consumer Health News Source Type: news

Three ways to manage pain without pills
(Natural News) Most of us greet each new day with excitement and joy, happy to be alive and enjoy at least a measure of good health. There are millions of Americans, however, for whom the days pass in a blur of chronic pain. The famous French physician, Dr. Albert Schweitzer, having observed the effects of... (Source: NaturalNews.com)
Source: NaturalNews.com - December 21, 2017 Category: Consumer Health News Source Type: news

Selective Cannabinoids for Chronic Neuropathic Pain Selective Cannabinoids for Chronic Neuropathic Pain
Are selective cannabinoids effective in treating neuropathic pain that's been refractory to recommended first and second-line medications?Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 21, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Chronic Pain & Me: A Mom ’s Tale
According to a report by the Institute of Medicine (IOM), more than 116 million Americans suffer from chronic pain. Managing (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - December 20, 2017 Category: Consumer Health News Source Type: news

Why patients are afraid of opioid analgesics - study on opioid perception in patients treated for chronic pain - Graczyk M, Borkowska A, Krajnik M.
INTRODUCTION     Opiophobia is deemed one of the key barriers in effective pain management.  OBJECTIVES    The study aimed to assess overall perception of opioids in cancer patients suffering from and treated for chronic pain, as well as determine th... (Source: SafetyLit)
Source: SafetyLit - December 20, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

7 medical devices combating the opioid crisis
[Image from unsplash.com]Opioid-related deaths have become an epidemic in the U.S., garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause more deaths than any other opioid type while incurring a high economic cost. The Council of Economic Advisers reports that the opioid crisis had an economic cost of $504 billion in 2015, and prescription opioid misuse increases healthcare and substanc...
Source: Mass Device - December 20, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Hospital Care Neurological Neuromodulation/Neurostimulation Pain Management Pharmaceuticals Avancen Halyard Health MedTech Myoscience nevro opioid crisis opioids Regenesis Biomedical Inc. Stimwave stjudemedical Source Type: news

Studies provide new insights on mosquito-borne chikungunya virus infection
(Wiley) The frequency of chronic joint pain after infection with chikungunya in a large Latin-American cohort was 25 percent at a median of 20-months post-infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2017 Category: International Medicine & Public Health Source Type: news

Pain in neck: Try THESE three ways to CURE chronic discomfort
PAIN IN NECK could be eased by Chinese massage and staying active, according to a new study. (Source: Daily Express - Health)
Source: Daily Express - Health - December 19, 2017 Category: Consumer Health News Source Type: news

Karlie Wilkinson suffers endometriosis
Karlie Wilkinson was diagnosed with the debilitating disorder endometriosis  at the aged of 19 after suffering from unbearable chronic pain and intense abdominal cramping. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2017 Category: Consumer Health News Source Type: news

Barriers and Facilitators in Chronic Pain Self-Management Barriers and Facilitators in Chronic Pain Self-Management
What factors do patients feel make their chronic pain management easier or harder?Pain Management Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2017 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

Is Chinese massage an effective and cost-effective treatment for chronic neck pain?
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study evaluating a form of Chinese massage, tuina, in patients with chronic neck pain found it to be effective, safe, and cost-effective compared to no treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2017 Category: International Medicine & Public Health Source Type: news

What is DIOS?
Discussion Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane receptor (CFTR). It is found in the epithelium of the bronchi, intestine, pancreatic duct and biliary tree. It regulates chloride, bicarbonate and water secretion. The heterozygous state helps prevent against secretory diarrhea, but the homozygous state causes thickened secretions in the hollow tubes of the lungs and digestive tract. There are multiple mutations (> 2000) which have been currently classified into classes depending on their protein production and activity. CF patients generally are l...
Source: PediatricEducation.org - December 18, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

What is Dissociation & Multiple Personality Disorder?
Dissociation is a mental process, which produces a lack of connection in a person’s thoughts, memories, feelings, actions, or sense of identity. During the period of time when a person is dissociating, certain information is not associated with other information as it normally would be. For example, during a traumatic experience, a person may dissociate the memory of the place and circumstances of the trauma from his ongoing memory, resulting in a temporary mental escape from the fear and pain of the trauma and, in some cases, a memory gap surrounding the experience. Because this process can produce changes in memory...
Source: Psych Central - December 17, 2017 Category: Psychiatry Authors: John M. Grohol, Psy.D. Tags: Disorders Dissociation Dissociative General Personality Source Type: news

The family which doesn't feel pain
The experience of six related Italians may help to find a new treatment for people with chronic pain. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 16, 2017 Category: Consumer Health News Source Type: news

The family that doesn't feel pain
The experience of six related Italians may help to find a new treatment for people with chronic pain. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 16, 2017 Category: Consumer Health News Source Type: news

Pain free
The experience of six related Italians may help to find a new treatment for people with chronic pain. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 16, 2017 Category: Consumer Health News Source Type: news

---
Katie Parker, CPNPFrom the desk of Katie Parker, CPNP   Over 93 million people travel over the winter holiday season.  Below are travel safety tips from the American Academy of Pediatrics (AAP) to help keep your family safe while traveling!Tips for flying with a baby:*Babies tend to sleep more reliably at nighttime than they do during naptime travel after the first few weeks of life.  If you and your baby can sleep on the plane, a late-night flight may be the right way to go!*It is recommended that babies have their 2 month vaccinations prior to flying.Purchasing airline tickets:*Turbulence is the ...
Source: Pediatric Health Associates - December 15, 2017 Category: Pediatrics Tags: Safety Vaccination Information Source Type: news

Tips for Flying with a Baby
Katie Parker, CPNPFrom the desk of Katie Parker, CPNP   Over 93 million people travel over the winter holiday season.  Below are travel safety tips from the American Academy of Pediatrics (AAP) to help keep your family safe while traveling!Tips for flying with a baby:*Babies tend to sleep more reliably at nighttime than they do during naptime travel after the first few weeks of life.  If you and your baby can sleep on the plane, a late-night flight may be the right way to go!*It is recommended that babies have their 2 month vaccinations prior to flying.Purchasing airline tickets:*Turbulence is the ...
Source: Pediatric Health Associates - December 15, 2017 Category: Pediatrics Tags: Safety Vaccination Information Source Type: news

Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Intranasal abuse-deterrent claim to be added to ARYMO ER prescribing information label WAYNE, Pa., Dec. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical compan... Biopharmaceuticals, FDA Egalet Corp, ARYMO ER, morphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2017 Category: Pharmaceuticals Source Type: news

Genetics may explain chronic post-surgery pain
Some patients experience chronic pain after surgery. New research suggests genetics likely plays a role. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 14, 2017 Category: Consumer Health News Source Type: news